FDA Inspection 1194790 — LifeShare Blood Centers
The FDA completed an inspection of LifeShare Blood Centers on Dec 8, 2022 in Monroe, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 8, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Monroe, LA (United States)